Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net revenue $ 71,229 $ 75,858 $ 221,647 $ 233,774
Operating expenses:        
Cost of revenue [1] 17,832 19,862 54,851 58,276
Selling and marketing 15,116 18,786 50,756 55,283
Research and development 16,654 17,367 51,418 53,503
General and administrative 11,581 10,747 35,005 33,688
Depreciation and amortization 11,593 11,537 34,813 33,686
Restructuring and related 3,231 1,280 5,248 7,112
Total operating costs and expenses 76,007 79,579 232,091 241,548
Loss from operations (4,778) (3,721) (10,444) (7,774)
Other income (expense), net:        
Change in fair value of warrant liabilities 276 4,216 929 1,381
Interest income, net 1,127 1,364 3,921 3,521
Other (loss) income, net (256) (198) (626) 906
Total other income, net 1,147 5,382 4,224 5,808
(Loss) income before income taxes (3,631) 1,661 (6,220) (1,966)
Income tax benefit (expense) 534 2,139 (55) 2,437
Net (loss) income $ (3,097) $ 3,800 $ (6,275) $ 471
Net loss per share attributable to Class A and Class B common stockholders:        
Basic (USD per share) $ (0.02) $ 0.03 $ (0.05) $ 0.00
Diluted (USD per share) $ (0.02) $ 0.03 $ (0.05) $ 0.00
Weighted average shares of common stock outstanding:        
Basic (shares) 125,007 133,351 130,997 132,546
Diluted (shares) 125,007 149,655 130,997 148,911
[1] Amounts exclude depreciation and amortization.